Versant Ventures V, LLC

Insider Reports History

Entity
Company
Location
One Sansome Street, Suite 1650, San Francisco, CA
Signature
Versant Ventures V, LLC, By /s/ Max Eisenberg, Chief Operating Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Versant Ventures V, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Turnstone Biologics Corp. 10%+ Owner Common Stock 2.73M Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. 10%+ Owner Common Stock 275K Jul 25, 2023 By Versant Vantage II, L.P.
Turnstone Biologics Corp. 10%+ Owner Common Stock 207K Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. 10%+ Owner Common Stock 90.9K Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. 10%+ Owner Common Stock 82K Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Repare Therapeutics Inc. 10%+ Owner Common Shares 0 $2.43 Jun 6, 2022 Direct
Repare Therapeutics Inc. 10%+ Owner Common Shares 0 $2.43 Jun 6, 2022 Indirect
Turnstone Biologics Corp. 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. 10%+ Owner Series A Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. 10%+ Owner Series B-1 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. 10%+ Owner Series B-2 Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Affiliates Fund V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Ophthalmic Affiliates Fund I, L.P.
Turnstone Biologics Corp. 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V (Canada) LP
Turnstone Biologics Corp. 10%+ Owner Series C Preferred Stock 0 Jul 25, 2023 By Versant Venture Capital V, L.P.
Turnstone Biologics Corp. 10%+ Owner Series D Preferred Stock 0 Jul 25, 2023 By Versant Vantage II, L.P.

Insider Reports Filed by Versant Ventures V, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSBX Turnstone Biologics Corp. Jul 25, 2023 26 $2.7M 4 Jul 27, 2023 10%+ Owner
TSBX Turnstone Biologics Corp. Jul 20, 2023 0 $0 3 Jul 20, 2023 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 3, 2022 15 -$9.19M 4 Jun 7, 2022 10%+ Owner
RPTX Repare Therapeutics Inc. Aug 5, 2021 5 $0 4 Aug 9, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. Jun 1, 2021 5 $0 4 Jun 3, 2021 10%+ Owner
RPTX Repare Therapeutics Inc. May 5, 2021 10 $0 4 May 7, 2021 10%+ Owner